147 related articles for article (PubMed ID: 37082061)
1. Alpha-L-fucosidase levels in patients with oral submucous fibrosis and controls: A comparative study.
Suresh H; Gunasekaran N; James A; Krishnan R; Thayalan DK; Kumar AR
J Oral Maxillofac Pathol; 2022; 26(4):594. PubMed ID: 37082061
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of lactate dehydrogenase enzyme activity in saliva and serum of oral submucous fibrosis patients.
Sivaramakrishnan M; Sivapathasundharam B; Jananni M
J Oral Pathol Med; 2015 Jul; 44(6):449-52. PubMed ID: 25224513
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of salivary tumor necrosis factor
Abdul Aziz Shaikh S; Denny E C; Kumarchandra R; Natarajan S; Sunny J; Shenoy N; K P N
Front Oral Health; 2024; 5():1375162. PubMed ID: 38595736
[TBL] [Abstract][Full Text] [Related]
4. Estimation of Salivary and Serum Lactate Dehydrogenase in Oral Submucous Fibrosis.
Mishra S; Kritika C; Bajoria AA; Choudhury P; Sahoo SK; Sangamesh NC
J Int Soc Prev Community Dent; 2018; 8(4):289-295. PubMed ID: 30123759
[TBL] [Abstract][Full Text] [Related]
5. Assessment of lactate dehydrogenase enzyme levels in saliva and serum of oral submucous fibrosis and leukoplakia patients.
Panda A; Behura SS; Bhuyan L; Dash KC; Kumar V; Mukherjee S
J Oral Maxillofac Pathol; 2020; 24(1):183. PubMed ID: 32508472
[TBL] [Abstract][Full Text] [Related]
6. Up regulation of serum L fucose glycoprotein as a diagnostic biomarker for dysplasia in oral sub mucous fibrosis patients.
Vaddamanu SK; Saini RS; Veerabasavaiah BT; Alhamoudi FH; Ali F Alshadidi A; Lo Giudice A; Cicciù M; Minervini G
Heliyon; 2024 Jan; 10(2):e24211. PubMed ID: 38312635
[TBL] [Abstract][Full Text] [Related]
7. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker.
Shah M; Telang S; Raval G; Shah P; Patel PS
Cancer; 2008 Jul; 113(2):336-46. PubMed ID: 18521898
[TBL] [Abstract][Full Text] [Related]
8. Estimation of Salivary 8-Hydroxydeoxyguanosine (8-OHdG) as a Potential Biomarker in Assessing Progression towards Malignancy: A Case-Control Study.
Nandakumar A; Nataraj P; James A; Krishnan R; K M M
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2325-2329. PubMed ID: 32856861
[TBL] [Abstract][Full Text] [Related]
9. Salivary malondialdehyde in oral submucous fibrosis - A marker for oxidative damage.
Ganta SR; Chittemsetti S; Sravya T; Guttikonda VR
J Oral Maxillofac Pathol; 2021; 25(1):82-87. PubMed ID: 34349416
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of serum and salivary immunoglobulin G and A levels with total serum protein in oral submucous fibrosis patients: A case control study.
Kandasamy M; Jaisanghar N; Austin RD; Srivastava KC; Anusuya GS; Anisa N
J Pharm Bioallied Sci; 2016 Oct; 8(Suppl 1):S126-S132. PubMed ID: 27829763
[TBL] [Abstract][Full Text] [Related]
11. Lactate dehydrogenase as a biomarker in oral cancer and oral submucous fibrosis.
Kallalli BN; Rawson K; Muzammil ; Singh A; Awati MA; Shivhare P
J Oral Pathol Med; 2016 Oct; 45(9):687-690. PubMed ID: 27132033
[TBL] [Abstract][Full Text] [Related]
12. Expression of salivary levels of S100A7 in oral submucous fibrosis and oral leukoplakia.
Fathima R; Ramamoorthi R; Gopalakrishnan S; Jayaseelan VP; Muniapillai S
J Oral Maxillofac Pathol; 2024; 28(1):84-89. PubMed ID: 38800445
[TBL] [Abstract][Full Text] [Related]
13. 8-Isoprostane: A salivary oxidative stress biomarker for oral submucous fibrosis and oral squamous cell carcinoma.
Meera S; Sarangarajan R; Rajkumar K
J Oral Maxillofac Pathol; 2020; 24(2):279-284. PubMed ID: 33456237
[TBL] [Abstract][Full Text] [Related]
14. Study of the Role of Salivary Lactate Dehydrogenase in Habitual Tobacco Chewers, Oral Submucous Fibrosis and Oral Cancer as a Biomarker.
Mantri T; Thete SG; Male V; Yadav R; Grover I; Adsure GR; Kulkarni D
J Contemp Dent Pract; 2019 Aug; 20(8):970-973. PubMed ID: 31797856
[TBL] [Abstract][Full Text] [Related]
15. Salivary Lactate Dehydrogenase as a Potential Biomarker in Oral Potentially Malignant Disorders and Head & Neck Cancer- A Systematic Review and Meta-analysis.
S LK; Naik Z; Lagali-Jirge V; M S; Panwar A; Keluskar V
Gulf J Oncolog; 2023 Jan; 1(41):78-99. PubMed ID: 36804163
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of micronutrient status in serum and saliva of oral submucous fibrosis patients: A clinicopathological study.
Shetty SR; Babu S; Kumari S; Shetty P; Vijay R; Karikal A
Indian J Med Paediatr Oncol; 2012 Oct; 33(4):224-6. PubMed ID: 23580824
[TBL] [Abstract][Full Text] [Related]
17. Expression of Ki67 as potential biomarker in oral submucous fibrosis: An immunohistochemical study.
Kamala KA; Kanetkar SR; Datkhile KD; Sankethguddad S
Indian J Dent Res; 2022; 33(3):272-276. PubMed ID: 36656187
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of trace elements in the saliva and serum of patients with oral submucous fibrosis and squamous cell carcinoma.
Kumar V; Kumari N; Ealla KKR; Gour S; Srivastava H; Rallabhandi S
Mol Clin Oncol; 2024 Mar; 20(3):18. PubMed ID: 38332992
[TBL] [Abstract][Full Text] [Related]
19. Alpha-l-fucosidase: a novel serum biomarker to predict prognosis in early stage esophageal squamous cell carcinoma.
Yu X; Zhang R; Yang T; Zhang M; Xi K; Lin Y; Wen Y; Wang G; Huang Z; Zhang X; Zhang L
J Thorac Dis; 2019 Sep; 11(9):3980-3990. PubMed ID: 31656672
[TBL] [Abstract][Full Text] [Related]
20. Role of aberrant glycosylation enzymes in oral cancer progression.
Vajaria BN; Patel KA; Patel PS
J Carcinog; 2018; 17():5. PubMed ID: 30294247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
